Joshua Jennings
Stock Analyst at TD Cowen
(3.07)
# 1,317
Out of 5,072 analysts
74
Total ratings
44.93%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Maintains: Buy | $36 → $20 | $17.35 | +15.27% | 3 | Nov 5, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $25 → $15 | $6.02 | +149.17% | 2 | Nov 5, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $85 → $50 | $32.27 | +54.94% | 4 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Buy | $100 → $84 | $61.69 | +36.16% | 2 | Oct 31, 2025 | |
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.32 | +165.15% | 3 | Aug 12, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $3.85 | +289.61% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $328.82 | -1.47% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $101.36 | +8.52% | 7 | Dec 12, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $146.00 | -17.81% | 9 | Nov 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $1.44 | +3,372.22% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $143 → $119 | $97.07 | +22.59% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $42.54 | +41.04% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $75.01 | +6.65% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $4.47 | +906.71% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $86.82 | -19.37% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $206.67 | -10.49% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $18.66 | +114.36% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $375.08 | +6.64% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $69.00 | -13.04% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $21.84 | +55.68% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $6.50 | +176.92% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $18.20 | +37.36% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $128.05 | +1.52% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.47 | +102.43% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $105.35 | +11.06% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $2.49 | +17,972.29% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $21.83 | -45.03% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $195.49 | +40.67% | 1 | Feb 7, 2020 |
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36 → $20
Current: $17.35
Upside: +15.27%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $6.02
Upside: +149.17%
PROCEPT BioRobotics
Nov 5, 2025
Maintains: Buy
Price Target: $85 → $50
Current: $32.27
Upside: +54.94%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100 → $84
Current: $61.69
Upside: +36.16%
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.32
Upside: +165.15%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $3.85
Upside: +289.61%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $328.82
Upside: -1.47%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $101.36
Upside: +8.52%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $146.00
Upside: -17.81%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $1.44
Upside: +3,372.22%
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $97.07
Upside: +22.59%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $42.54
Upside: +41.04%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $75.01
Upside: +6.65%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $4.47
Upside: +906.71%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $86.82
Upside: -19.37%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $206.67
Upside: -10.49%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $18.66
Upside: +114.36%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $375.08
Upside: +6.64%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $69.00
Upside: -13.04%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $21.84
Upside: +55.68%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $6.50
Upside: +176.92%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $18.20
Upside: +37.36%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $128.05
Upside: +1.52%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.47
Upside: +102.43%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $105.35
Upside: +11.06%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $2.49
Upside: +17,972.29%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $21.83
Upside: -45.03%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $195.49
Upside: +40.67%